Evidently AI, a pioneering player in the realm of collaborative AI observability, has successfully secured $15 million in its latest funding round, a significant milestone that underscores the growing demand for robust AI monitoring solutions. As companies increasingly integrate artificial intelligence into their operations, the complexities and potential risks associated with AI deployments necessitate tools that can ensure performance, reliability, and ethical compliance. The newly raised capital will enable Evidently AI to enhance its already impressive suite of offerings, which includes open-source machine learning monitoring and advanced large language model (LLM) evaluation capabilities. By providing businesses with the ability to evaluate, test, and monitor any AI-powered product, Evidently AI empowers organizations to maintain transparency and control over their AI systems. This funding will facilitate further research and development, allowing the company to expand its platform’s functionalities and extend its outreach within the AI community. With the rising importance of AI observability in a time of increasing scrutiny of AI technologies, Evidently AI is poised to play a critical role in helping organizations navigate the complexities of AI implementation and monitoring. Through its commitment to open-source solutions, Evidently AI fosters a collaborative environment that promotes innovation, community engagement, and shared knowledge. As the company sets its sights on scaling its operations and improving its platform, this funding marks just the beginning of a transformative journey toward elevating AI accountability and performance across industries.
Evidently AI Secures $15 Million in Series A Funding for Groundbreaking AI Observability Platform
Get the full Evidently AI company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
P2 Science, Inc.
We are the New Green Chemistry Company with a mission to de-carbonize the chemical industry, using the power of green chemistry.
$23.0M Unknown
today
Backoffice Solutions, Inc.
Backoffice Solutions, Inc. (BSI) is a domestic corporation that offers back-office support to micro, small and medium Enterprises, sole proprietors or self-employed individuals. Registered under the Securities Exchange Commission (SEC) since 14 August 2012. Our company has worked with varied private sector companies and organizations, allowing us to develop expertise in the following sectors: * Online Market Place * Restaurants and Food Chains * Forwarding Business * Travel & Tours * Advertising & Marketing * Domestic Manpower Agency * Hotels, Resorts & Tourism * International Manning Agency * Training School * Ship Management
$163.5K Unknown
today
Evolve Neuro
Transforming ADHD diagnosis with proprietary neuroscience and AI. Our 10-minute EEG-based assessment unlocks scalable, evidence-backed insights — targeting a global market underserved by outdated, subjective methods.
$1.9M Seed
today
Phytolon
Phytolon offers natural food colors, uniquely positioned to comply with the consumers needs for healthy food, and with the industry requirements for cost-efficiency and high quality. Phytolon leverages a novel and sustainable fermentation-based technology by which betalain natural colors are produced in baker's yeast.
$23.6M Series b
today
OZOREON
Our (H)unit® is a robust offgrid adapted ozone generator, built to last. With proprietary components and design it can withstand any humidity in the feed gas. We offer it as a stand-alone product or included in an automation cabinet. As an add-on we also provide a customized offgrid power-supply kit. The beneficial combination of ozone and high humidity is a known fact in the industry, and has been documented for 80+ years. The synergistic effects causes higher oxidizing and disinfecting properties than a dry ozone treatment does. And OZOREON has the technology for it.
$320.0K Unknown
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Riboscience United States | Series a | $146.8M | today |
| 2 |  Passage Ticketing United States | Series a | $610.0K | today |
| 3 |  InvestorHub Australia | Series a | $3.0M | 1d ago |
| 4 |  Mister IA France | Series a | $10.0M | 1d ago |
| 5 |  OneReg New Zealand | Series a | $4.4M | 1d ago |